Form 4 Filing for Legend Biotech Corp

Carlos E. Santos, Chief Financial Officer of Legend Biotech Corp, reported a disposition of 5,430 ordinary shares on September 21, 2026. The shares were sold at a weighted average price of $9.14, with prices ranging from $8.905 to $9.325. This transaction resulted in 14,246 shares remaining. Additionally, 19,676 ordinary shares were acquired on the same date with a transaction price of $0.00. The acquisition is related to shares sold to satisfy withholding tax obligations upon the vesting of restricted share units. The Ordinary Shares may be represented by American Depositary Shares (ADSs), with each ADS representing two ordinary shares.